Will MagioncaldaWillMagioncalda

The underwriters in Exscientia’s $350.4 million initial public offering and concurrent $160 million private placements.

The underwriters in Sarepta Therapeutics’ $575 million public follow-on offering.

The underwriters in Krystal Biotech’s $200 million and $125 million public follow-on offerings.

The underwriters in Omega Therapeutics'' $144.6 million initial public offering.

The underwriters in Ambrx Biopharma’s $126 million initial public offering.

The underwriters in Valneva’s $107.6 million initial public offering and $102 million public follow-on offering.

Codiak BioSciences in its $82.5 million initial public offering and $66.4 million public follow-on offering.

HOOKIPA Pharma in its $84 million initial public offering.

The underwriters in Repare Therapeutics’ $253 million initial public offering and $101.2 million public follow-on offering.

The underwriters in Harmony Biosciences’ $147.6 million initial public offering.

The underwriters in Pandion Therapeutics’ $135 million initial public offering.

The underwriters in Arvinas’ $120 million initial public offering and $150 million and $400 million public follow-on offerings.

The underwriters in Immunomedics’ $420 million and $285 million public follow-on offerings.